Quarterly report · Q1

Period2023-01-01 → 2023-03-31
Filed2023-05-12
StandardIFRS
ConsolidatedYes
Data checks10 of 10 passed
Key figures · 40
MetricValuePeriodScopeSource row
Operating income−¥671m2023-01-01 → 2023-03-31Cons.Operating profit loss IFRS
Operating income¥2.5bn2022-01-01 → 2022-03-31Cons.Operating profit loss IFRS
Profit before tax−¥791m2023-01-01 → 2023-03-31Cons.Profit loss before tax IFRS
Profit before tax¥12.4bn2022-01-01 → 2022-12-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥3.6bn2022-01-01 → 2022-03-31Cons.Profit loss before tax IFRS
Net income (owners)−¥784m2023-01-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥10.1bn2022-01-01 → 2022-12-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥3.3bn2022-01-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income−¥792m2023-01-01 → 2023-03-31Cons.Profit loss IFRS
Net income¥3.3bn2022-01-01 → 2022-03-31Cons.Profit loss IFRS
Total assets¥223.8bnat 2023-03-31Cons.Assets IFRS
Total assets¥230.2bnat 2022-12-31Cons.Assets IFRS
Total assets¥212.7bnat 2022-03-31Cons.Total assets IFRS (5-year summary)
Total liabilities¥115.2bnat 2023-03-31Cons.Liabilities IFRS
Total liabilities¥118.7bnat 2022-12-31Cons.Liabilities IFRS
Net assets / equity¥108.7bnat 2023-03-31Cons.Equity IFRS
Net assets / equity¥111.5bnat 2022-12-31Cons.Equity IFRS
Net assets / equity¥103.6bnat 2022-03-31Cons.Equity IFRS
Net assets / equity¥98.3bnat 2021-12-31dCons.Equity IFRS
Equity (owners)¥108.7bnat 2023-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥111.6bnat 2022-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥103.6bnat 2022-03-31Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥46.1bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥54.3bnat 2022-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥38.7bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Operating cash flow−¥2.4bn2023-01-01 → 2023-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥12.0bn2022-01-01 → 2022-12-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow−¥2.4bn2022-01-01 → 2022-03-31Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥3.0bn2023-01-01 → 2023-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥4.4bn2022-01-01 → 2022-12-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥1.1bn2022-01-01 → 2022-03-31Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥3.1bn2023-01-01 → 2023-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥1.1bn2022-01-01 → 2022-12-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥1.5bn2022-01-01 → 2022-03-31Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥-15.972023-01-01 → 2023-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥203.652022-01-01 → 2022-12-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥65.852022-01-01 → 2022-03-31Cons.Basic earnings loss per share IFRS
Equity ratio48.6%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio48.5%at 2022-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio48.7%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 14
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-01-01 → 2023-03-31−¥208m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-03-31−¥610m
jpcrp040300-q1r_E00703-000Devicesreportable segmentsegment profit2023-01-01 → 2023-03-31−¥868m
jpcrp040300-q1r_E00703-000Industrial Materialsreportable segmentsegment profit2023-01-01 → 2023-03-31¥519m
jpcrp040300-q1r_E00703-000Medical Technologiesreportable segmentsegment profit2023-01-01 → 2023-03-31¥496m
—segment totalsegment profit2023-01-01 → 2023-03-31¥147m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-01-01 → 2023-03-31−¥60m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-01-01 → 2022-03-31−¥216m
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-03-31−¥248m
jpcrp040300-q1r_E00703-000Devicesreportable segmentsegment profit2022-01-01 → 2022-03-31¥1.4bn
jpcrp040300-q1r_E00703-000Industrial Materialsreportable segmentsegment profit2022-01-01 → 2022-03-31¥1.5bn
jpcrp040300-q1r_E00703-000Medical Technologiesreportable segmentsegment profit2022-01-01 → 2022-03-31¥7m
—segment totalsegment profit2022-01-01 → 2022-03-31¥3.0bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-01-01 → 2022-03-31¥2.7bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 715
ItemContextValueUnit
Dividends paid to owners of parent fin cf IFRSPrior1YTDDuration-1235000000JPY
Dividends paid to owners of parent fin cf IFRSCurrentYTDDuration-1718000000JPY
Other fin cf IFRSPrior1YTDDuration-JPY
Other fin cf IFRSCurrentYTDDuration-5000000JPY
Net cash provided by used in financing activities IFRSPrior1YTDDuration-1455000000JPY
Net cash provided by used in financing activities IFRSCurrentYTDDuration-3140000000JPY
Effect of exchange rate changes on cash and cash equivalents IFRSPrior1YTDDuration1271000000JPY
Effect of exchange rate changes on cash and cash equivalents IFRSCurrentYTDDuration325000000JPY
Net increase decrease in cash and cash equivalents IFRSPrior1YTDDuration-3667000000JPY
Net increase decrease in cash and cash equivalents IFRSCurrentYTDDuration-8250000000JPY
Cash and cash equivalents if different from bs balance IFRSPrior2YearInstant42330000000JPY
Cash and cash equivalents if different from bs balance IFRSPrior1YearInstant54325000000JPY
Cash and cash equivalents IFRSPrior1QuarterInstant38663000000JPY
Cash and cash equivalents IFRSCurrentQuarterInstant46075000000JPY
Sales to external customers IFRSPrior1YTDDuration_jpcrp040300-q1r_E00703-000IndustrialMaterialsReportableSegmentMember16785000000JPY
Sales to external customers IFRSPrior1YTDDuration_jpcrp040300-q1r_E00703-000DevicesReportableSegmentMember15957000000JPY
Sales to external customers IFRSPrior1YTDDuration_jpcrp040300-q1r_E00703-000MedicalTechnologiesReportableSegmentMember6685000000JPY
Sales to external customers IFRSPrior1YTDDuration_ReportableSegmentsMember39429000000JPY
Sales to external customers IFRSPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember1983000000JPY
Sales to external customers IFRSPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember41412000000JPY
Sales to external customers IFRSPrior1YTDDuration_ReconcilingItemsMember-JPY
Sales to external customers IFRSPrior1YTDDuration41412000000JPY
Intersegment sales IFRSPrior1YTDDuration_jpcrp040300-q1r_E00703-000IndustrialMaterialsReportableSegmentMember107000000JPY
Intersegment sales IFRSPrior1YTDDuration_jpcrp040300-q1r_E00703-000DevicesReportableSegmentMember3000000JPY
Intersegment sales IFRSPrior1YTDDuration_jpcrp040300-q1r_E00703-000MedicalTechnologiesReportableSegmentMember-JPY
Intersegment sales IFRSPrior1YTDDuration_ReportableSegmentsMember111000000JPY
Intersegment sales IFRSPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember240000000JPY
Intersegment sales IFRSPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember351000000JPY
Intersegment sales IFRSPrior1YTDDuration_ReconcilingItemsMember-351000000JPY
Intersegment sales IFRSPrior1YTDDuration-JPY
Net sales IFRSPrior1YTDDuration_jpcrp040300-q1r_E00703-000IndustrialMaterialsReportableSegmentMember16893000000JPY
Net sales IFRSPrior1YTDDuration_jpcrp040300-q1r_E00703-000DevicesReportableSegmentMember15961000000JPY
Net sales IFRSPrior1YTDDuration_jpcrp040300-q1r_E00703-000MedicalTechnologiesReportableSegmentMember6685000000JPY
Net sales IFRSPrior1YTDDuration_ReportableSegmentsMember39540000000JPY
Net sales IFRSPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember2223000000JPY
Net sales IFRSPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember41764000000JPY
Net sales IFRSPrior1YTDDuration_ReconcilingItemsMember-351000000JPY
Net sales IFRSPrior1YTDDuration41412000000JPY
Operating profit loss IFRSPrior1YTDDuration_jpcrp040300-q1r_E00703-000IndustrialMaterialsReportableSegmentMember1528000000JPY
Operating profit loss IFRSPrior1YTDDuration_jpcrp040300-q1r_E00703-000DevicesReportableSegmentMember1422000000JPY
Operating profit loss IFRSPrior1YTDDuration_jpcrp040300-q1r_E00703-000MedicalTechnologiesReportableSegmentMember7000000JPY
Operating profit loss IFRSPrior1YTDDuration_ReportableSegmentsMember2958000000JPY
Operating profit loss IFRSPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember-216000000JPY
Operating profit loss IFRSPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember2742000000JPY
Operating profit loss IFRSPrior1YTDDuration_ReconcilingItemsMember-248000000JPY
Operating profit loss IFRSPrior1YTDDuration2494000000JPY
Finance income IFRSPrior1YTDDuration_jpcrp040300-q1r_E00703-000IndustrialMaterialsReportableSegmentMember-JPY
Finance income IFRSPrior1YTDDuration_jpcrp040300-q1r_E00703-000DevicesReportableSegmentMember-JPY
Finance income IFRSPrior1YTDDuration_jpcrp040300-q1r_E00703-000MedicalTechnologiesReportableSegmentMember-JPY
Finance income IFRSPrior1YTDDuration_ReportableSegmentsMember-JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 10 of 10 passed
balance sheet identityconsolidated 2022-12-31pass rounding
balance sheet identityconsolidated 2023-03-31pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-03-31pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-03-31pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-03-31pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass